Cannabis Business Times On 'Jersey Matters'

Cannabis Business Times Editor Noelle Skodzinski speaks with Larry Mendte on "Jersey Matters" about the magazine's focus on the growth of the industry and the future of cannabis legalization.

May 17, 2016

German Cannabis Market Establishes Foundation for Global Industry Expansion (Op-Ed)

Innovating for the Benefit of Patients in Medical Cannabis (Opinion)

Rescheduling Update: How Long Is the Wait? What’s Next?

Mitch Meyers on How to 'Manage the Chaos' in Cannabis

German Cannabis Market Establishes Foundation for Global Industry Expansion (Op-Ed)

The fact that legal cannabis in Germany is more affordable than the illegal market is revolutionary for the global cannabis industry to date.

Germany Graphic

Innovating for the Benefit of Patients in Medical Cannabis (Opinion)

Poor bioavailability formulations in orally delivered medical cannabis have left an innovation gap for patients.

Stenocare 365250395

Rescheduling Update: How Long Is the Wait? What’s Next?

Government affairs and policy expert David Mangone tells us what we can expect from the DEA as weeks pass following the public comment period, including insights on the DEA’s final review and if a hearing is likely to be granted.

David Mangone Interview Top Story Image

Mitch Meyers on How to 'Manage the Chaos' in Cannabis

The founder of Missouri's BeLeaf Medical says women are 'uniquely suited' to be leaders in the male-dominated industry.

Mitch Meyers, founder, BeLeaf Medical

7 Takeaways From the Feds' Cannabis Rescheduling Recommendation

Attorney Jonathan Havens outlines what stood out for him most after reviewing the 252-page document released by the U.S. Department of Health & Human Services.

Opinion Top Story Havens 948x514

Opinion: The Cannabis Industry Must Prioritize Worker Safety, Invest in PPE

The hazards associated with cannabis production are well-documented, and it's time for the industry to step up and prioritize the health and safety of its employees.

Opinion Top Story Roggen 948x514

Federal Government Continues to Withhold Key Cannabis Scheduling Recommendation Letter Despite FOIA Requests, Lawsuit

After nearly three months and multiple Freedom of Information Act requests, the U.S. Department of Health and Human Services still has not publicly confirmed that it recommended cannabis be reclassified as a Schedule III controlled substance. One attorney who filed a lawsuit to obtain the letter calls the situation "asinine" and "profoundly disappointing."

A screenshot of the redacted letter from the U.S. Department of Health and Human Services Cannabis Business Times received in response to its Freedom of Information Act Request.

A Positive Sign For Schedule III

In Vienna, a U.S. state department legal adviser champions member-state discretion over domestic drug policy, potentially removing the obstacle the Single Convention drug treaty could pose to cannabis reform.

Opinion Top Story Pennington

The Cannabist Co. Chief Commercial Officer Jesse Channon Talks About the Columbia Care Rebrand

Channon shares the inspiration behind the company’s new identity and insight into what it takes to rebrand a multistate cannabis operation.

Opinion: HHS Rescheduling Recommendation is 'About Damn Time'

The U.S. Department of Health and Human Services recognition that cannabis should no longer be classified in the same category as heroin is an event to be celebrated. But the trajectory of U.S. policy deserves to be mourned.

Darren Weiss, President, Verano

8 Tips for Protecting Outdoor Cannabis Crops Against Heavy Rain During Harvest Season: UPDATED

Cannabis and hemp growers should take preventative measures to guard against crop damage during periods of heavy rains—and know what to do with rain-soaked plants in the aftermath.

Rainwaterdrainingoffroof Adobestock Credit Igorbatenev Resized

Opinion: Rescheduling Is Recriminalizing, Descheduling Is Decriminalizing

President of cannabis genetics company DNA Genetics, Rezwan Khan, weighs in on Biden's cannabis policy reform plan and how rescheduling or descheduling the plant would impact the industry.

Rez

Page 1 of 50